This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: C&c Research Laboratories. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Seunghee Kim: Innovator in Heterocyclic Derivatives
Introduction
Seunghee Kim is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic derivatives. Her work focuses on compounds that have potential therapeutic applications.
Latest Patents
Seunghee Kim holds a patent for "Heterocyclic derivatives and use thereof." This patent describes a heterocyclic derivative represented by formula (I), or a pharmaceutically acceptable salt or a stereoisomer thereof. The compound has an inhibitory effect on the activation of the STAT3 protein, making it useful for the prevention or treatment of diseases associated with the activation of this protein. She has 1 patent to her name.
Career Highlights
Seunghee Kim is currently employed at C&C Research Laboratories, where she continues to innovate and develop new pharmaceutical compounds. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of her notable coworkers include Chan Hee Park and Sang Hwi Lee. Their collaborative efforts contribute to the research and development initiatives at C&C Research Laboratories.
Conclusion
Seunghee Kim's contributions to the field of pharmaceuticals through her innovative work on heterocyclic derivatives highlight her role as a key inventor. Her research has the potential to impact the treatment of diseases linked to the STAT3 protein.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile